|
|
| | 3-Quinolinecarboxamide, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-N-[4-[[[2-(1-piperidinyl)ethyl]amino]carbonyl]phenyl]- Basic information |
| | 3-Quinolinecarboxamide, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-N-[4-[[[2-(1-piperidinyl)ethyl]amino]carbonyl]phenyl]- Chemical Properties |
| Boiling point | 818.4±65.0 °C(Predicted) | | density | 1.263±0.06 g/cm3(Predicted) | | form | Solid | | pka | 11.17±0.70(Predicted) | | color | White to off-white |
| | 3-Quinolinecarboxamide, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-N-[4-[[[2-(1-piperidinyl)ethyl]amino]carbonyl]phenyl]- Usage And Synthesis |
| Uses | microRNA-21-IN-1 (compound A7) is an efficient microRNA inhibitor. microRNA-21-IN-1 has antiproliferative activity against Hela and HCT-116 cells with IC50s of 5.5 μM and 2.8 μM respectively, as well as promotes apoptosis of Hela cells. microRNA-21-IN-1 upregulates the expression of microRNA-21 downstream functional targets (PTEN, EGR1 and SLIT2). microRNA-21-IN-1 can be used for researching anticancer[1]. | | References | [1] Xi XX, et al. Identification of benzamides derivatives of norfloxacin as promising microRNA-21 inhibitors via repressing its transcription. Bioorg Med Chem. 2022;66:116803. DOI:10.1016/j.bmc.2022.116803 |
| | 3-Quinolinecarboxamide, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-N-[4-[[[2-(1-piperidinyl)ethyl]amino]carbonyl]phenyl]- Preparation Products And Raw materials |
|